Clinical Trials Browser

Phase 1/2 × Craniopharyngioma × Clear all

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT06970145 2025-11-18

Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma

Phase 1/2 Recruiting

57 enrolled

CNS

Craniopharyngioma

NCT01061775 2019-10-08

Effects of Exenatide on Hypothalamic Obesity

Phase 1/2 Completed

19 enrolled 17 charts

CNS

Craniopharyngioma, Sexual Infantilism

NCT00003461 2014-08-21

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors

Phase 1/2 Completed

CNSSarcoma

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasm Metastasis, Neuroblastoma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Gliosarcoma

Clinical Trials

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma

Effects of Exenatide on Hypothalamic Obesity

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors